The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.66
Bid: 26.64
Ask: 26.70
Change: -0.06 (-0.22%)
Spread: 0.06 (0.225%)
Open: 26.60
High: 26.94
Low: 26.48
Prev. Close: 26.72
HMSO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Chief Executive appointment

30 Sep 2020 07:00

RNS Number : 5048A
Hammerson PLC
30 September 2020
 

Hammerson plc (the Company)

Directorate Change

30 September 2020

 

This announcement contains inside information.

 

Chief Executive appointment

 

Hammerson plc ("Hammerson") is pleased to announce the appointment of Rita-Rose Gagné as Chief Executive Officer ("CEO") and Executive Director.

 

Ms Gagné was most recently President of Growth Markets at the global real estate company Ivanhoé Cambridge where she had responsibility for $7.6bn of real estate assets across Asia Pacific and Latin America.

 

She joined Ivanhoé Cambridge in 2006 and held a variety of roles from Senior Vice President, Legal Affairs and General Counsel at Société immobilière Trans-Québec (SITQ) to Executive Vice President of Global Strategy, Portfolio Management and Investment Funds at Ivanhoé Cambridge. As Executive Vice President, Rita-Rose was tasked with developing, leading and executing the investment strategy in Asia and Latin America, prior to being made President of Growth Markets.

 

Ms Gagné is also a lawyer and holds an MBA from McGill-HEC Montreal. During her career, she has worked in property markets across the world, including the UK, France and Germany, and her expertise spans across various asset classes and mixed-use assets, including residential, retail, office and logistics.

 

It is anticipated that she will take up her new role with Hammerson before the end of the year. David Atkins will continue to serve as CEO until Ms Gagné joins the Company.

 

Robert Noel, Hammerson, Chair of the Board, said: "I am delighted that Rita-Rose will join Hammerson as our next CEO. She has an excellent track record in international real estate investment, building high-quality teams, developing strategic partnerships, execution and delivering results. On behalf of the Board, and all colleagues in the business, I look forward to welcoming Rita-Rose to Hammerson and working with her when she joins."

 

Rita-Rose Gagné, added: "The retail and real estate sectors are going through a period of unprecedented change which makes this a very exciting time to be joining the business. I look forward to working with Hammerson's experienced team and all its stakeholders to both navigate through the challenges but also seek out the opportunities to create value moving forward." 

 

Rita-Rose Gagné's terms on appointment:

Rita-Rose Gagné's employment terms will be in line with Hammerson's Directors' Remuneration Policy (the "Remuneration Policy"), which has been approved by shareholders. Her gross annual salary will be £672,000 and her pension allowance will be 10% of base salary. Upon joining, she will receive a Restricted Share Scheme award of 150% of salary in line with the Remuneration Policy. She will receive a gross relocation allowance of £400,000 in line with the Remuneration Policy.

There is no buyout of or compensation for previous remuneration packages. Full details will be disclosed in the 2020 Directors' Remuneration Report.

 

There are no other matters to disclose under Listing Rule 9.6.13.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

Ends

 

For further information, please contact

 

Investor Contact

Josh Warren, Hammerson, Head of Investor Relations

Tel: +44 20 7887 1053

Josh.warren@hammerson.com

 

Media Contact

Catrin Sharp, Hammerson, Head of Corporate Communications

Tel: +44 20 7887 1063

Catrin.sharp@hammerson.com

 

FTI Consulting

John Waples

Tel: +44 20 3727 1000/ 07717 814 520

John.waples@fticonsulting.com

 

Dido Laurimore

Tel: +44 20 3727 1000/ 0780 1654424

dido.laurimore@fticonsulting.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALLMPTMTTTBLM
Date   Source Headline
25th Apr 20242:00 pmRNSResult of AGM
16th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20244:30 pmRNSHolding(s) in Company
9th Apr 202410:30 amRNSDirector/PDMR Shareholding
28th Mar 20243:15 pmRNSTotal Voting Rights
26th Mar 20243:00 pmRNSDirector/PDMR Shareholding
25th Mar 20249:00 amRNSDividend Currency Conversion Announcement
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 202411:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20242:45 pmRNSCompletion of sale of Union Square
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 202410:45 amRNSNotification of Share Repurchase Programme
6th Mar 20243:15 pmRNSHolding(s) in Company
5th Mar 20249:30 amRNSHolding(s) in Company
29th Feb 20247:01 amRNSDividend Declaration
29th Feb 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSDisposal
1st Feb 202410:30 amRNSNotification of Full Year Results
25th Jan 20249:13 amRNSDirector Declaration
8th Jan 20243:00 pmRNSHolding(s) in Company
27th Dec 202311:00 amRNSDirector Declaration
20th Dec 20239:30 amRNSHolding(s) in Company
19th Dec 202312:00 pmRNSHolding(s) in Company
15th Dec 20235:00 pmRNSHolding(s) in Company
4th Dec 202312:30 pmRNSHolding(s) in Company
30th Nov 20231:30 pmRNSHolding(s) in Company
30th Nov 202310:00 amRNSBlock listing Interim Review
17th Nov 20231:45 pmRNSHolding(s) in Company
19th Oct 20233:00 pmRNSDirector/PDMR Shareholding
17th Oct 20239:00 amRNSDirector/PDMR Shareholding
11th Oct 20233:45 pmRNSDirector/PDMR Shareholding
9th Oct 20234:15 pmRNSDirector/PDMR Shareholding
6th Oct 20234:00 pmRNSDirector/PDMR Shareholding
5th Oct 20234:00 pmRNSDirector/PDMR Shareholding
20th Sep 20239:00 amRNSHolding(s) in Company
8th Sep 20231:10 pmRNSResults of bond tap issuance and tender offer
8th Sep 20231:00 pmRNSFinal Results of Bond Tender Offers
8th Sep 20239:00 amRNSIndicative Results of Bond Tender Offers
5th Sep 20239:00 amRNSHolding(s) in Company
31st Aug 202312:30 pmRNSHammerson Issues £100m Bond Tap
31st Aug 202311:15 amRNSBond Tender Offers
22nd Aug 20232:45 pmRNSHolding(s) in Company
21st Aug 20233:30 pmRNSHolding(s) in Company
18th Aug 20233:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.